Physicians' attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey

Publikationstyp:
Zeitschriftenaufsatz
Metadaten:
Autoren
  • Marlene Stoll
  • Lara Hubenschmid
  • Cora Koch
  • Klaus Lieb
  • Boris Egloff
Autoren-URL
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000817900500011&DestLinkType=FullRecord&DestApp=WOS_CPL
DOI
10.1136/bmjopen-2021-055963
Externe Identifier
  • Clarivate Analytics Document Solution ID: 2M7UQ
  • PubMed Identifier: 35750457
ISSN
2044-6055
Ausgabe der Veröffentlichung
6
Zeitschrift
BMJ OPEN
Schlüsselwörter
  • health policy
  • protocols & guidelines
  • medical ethics
Artikelnummer
ARTN e055963
Datum der Veröffentlichung
2022
Status
Published
Titel
Physicians' attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey
Sub types
  • Article
Ausgabe der Zeitschrift
12

Datenquelle: Web of Science (Lite)

Andere Metadatenquellen:
Abstract
<jats:sec><jats:title>Objectives</jats:title><jats:p>To investigate German physicians’ attitudes towards and experiences with voluntary disclosure of payments by pharmaceutical companies in a public database and their impact on future decisions for or against disclosure.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>A national cross-sectional survey conducted in 2018 among physicians who voluntarily disclosed at least one payment in the German transparency regulation.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>Retrospective paper-pencil questionnaire about attitudes towards and experiences with voluntary payment disclosures in the first (2015) and second (2016) years of the German transparency regulation.</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>German physicians who disclosed either in the first year only, the second year only, or in both years of the transparency regulation.</jats:p></jats:sec><jats:sec><jats:title>Primary outcomes</jats:title><jats:p>(1) The probability to disclose in 2016, predicted by physicians’ experience of reactions from others in 2015, descriptive norms and attitudes towards transparency; (2) Frequency and (3) Content of reactions from others in 2015 compared with 2016.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Data of 234 respondents were analysed (n=42, 45 and 147 physicians who disclosed in 2015, 2016 or both years, respectively). The probability to disclose in 2016 was not predicted by perceived reactions, norms or attitudes towards transparency (p&gt;0.01). Most participants reported not to have received any reactions by patients (190/234, 81%), colleagues (128/234, 55%) or the private environment (153/234, 65%). Neither frequency nor content of reactions differed between the first and second years (scale 1–5; frequency: <jats:italic>Mdn</jats:italic><jats:sub>2015,2016</jats:sub> = 1.33 vs 1.00, <jats:italic>r</jats:italic><jats:sub>b</jats:sub>=−0.17, p&gt;0.01; content: <jats:italic>Mdn</jats:italic><jats:sub>2015,2016</jats:sub> = 3.00 vs 3.00, <jats:italic>r</jats:italic><jats:sub>b</jats:sub>=0.19, p&gt;0.01). However, media reporting, fear of reputational damage and a feeling of being defamed were mentioned as reasons for non-disclosure.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>While confirmatory analyses did not provide significant results, descriptive analyses showed that participants who voluntarily disclose payments mainly do not experience any reactions towards their disclosures but report fears about losing their reputation due to disclosures.</jats:p></jats:sec>
Autoren
  • Marlene Stoll
  • Lara Hubenschmid
  • Cora Koch
  • Klaus Lieb
  • Boris Egloff
DOI
10.1136/bmjopen-2021-055963
eISSN
2044-6055
ISSN
2044-6055
Ausgabe der Veröffentlichung
6
Zeitschrift
BMJ Open
Sprache
en
Online publication date
2022
Paginierung
e055963 - e055963
Datum der Veröffentlichung
2022
Status
Published
Herausgeber
BMJ
Herausgeber URL
http://dx.doi.org/10.1136/bmjopen-2021-055963
Datum der Datenerfassung
2022
Titel
Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey
Ausgabe der Zeitschrift
12

Datenquelle: Crossref

Abstract
<h4>Objectives</h4>To investigate German physicians' attitudes towards and experiences with voluntary disclosure of payments by pharmaceutical companies in a public database and their impact on future decisions for or against disclosure.<h4>Design</h4>A national cross-sectional survey conducted in 2018 among physicians who voluntarily disclosed at least one payment in the German transparency regulation.<h4>Setting</h4>Retrospective paper-pencil questionnaire about attitudes towards and experiences with voluntary payment disclosures in the first (2015) and second (2016) years of the German transparency regulation.<h4>Participants</h4>German physicians who disclosed either in the first year only, the second year only, or in both years of the transparency regulation.<h4>Primary outcomes</h4>(1) The probability to disclose in 2016, predicted by physicians' experience of reactions from others in 2015, descriptive norms and attitudes towards transparency; (2) Frequency and (3) Content of reactions from others in 2015 compared with 2016.<h4>Results</h4>Data of 234 respondents were analysed (n=42, 45 and 147 physicians who disclosed in 2015, 2016 or both years, respectively). The probability to disclose in 2016 was not predicted by perceived reactions, norms or attitudes towards transparency (p>0.01). Most participants reported not to have received any reactions by patients (190/234, 81%), colleagues (128/234, 55%) or the private environment (153/234, 65%). Neither frequency nor content of reactions differed between the first and second years (scale 1-5; frequency: <i>Mdn</i><sub>2015,2016</sub> = 1.33 vs 1.00, <i>r</i><sub>b</sub>=-0.17, p>0.01; content: <i>Mdn</i><sub>2015,2016</sub> = 3.00 vs 3.00, <i>r</i><sub>b</sub>=0.19, p>0.01). However, media reporting, fear of reputational damage and a feeling of being defamed were mentioned as reasons for non-disclosure.<h4>Conclusions</h4>While confirmatory analyses did not provide significant results, descriptive analyses showed that participants who voluntarily disclose payments mainly do not experience any reactions towards their disclosures but report fears about losing their reputation due to disclosures.
Addresses
  • Department of Psychiatry and Psychotherapy, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany marlene.stoll@unimedizin-mainz.de.
Autoren
  • Marlene Stoll
  • Lara Hubenschmid
  • Cora Koch
  • Klaus Lieb
  • Boris Egloff
DOI
10.1136/bmjopen-2021-055963
eISSN
2044-6055
Externe Identifier
  • PubMed Identifier: 35750457
  • PubMed Central ID: PMC9234799
Funding acknowledgements
  • Volkswagen Foundation: A118085
Open access
true
ISSN
2044-6055
Ausgabe der Veröffentlichung
6
Zeitschrift
BMJ open
Schlüsselwörter
  • Humans
  • Pharmaceutical Preparations
  • Retrospective Studies
  • Cross-Sectional Studies
  • Attitude
  • Disclosure
  • Drug Industry
  • Conflict of Interest
  • Physicians
Sprache
eng
Medium
Electronic
Online publication date
2022
Open access status
Open Access
Paginierung
e055963
Datum der Veröffentlichung
2022
Status
Published
Publisher licence
CC BY-NC
Datum der Datenerfassung
2022
Titel
Physicians' attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey.
Sub types
  • Research Support, Non-U.S. Gov't
  • research-article
  • Journal Article
Ausgabe der Zeitschrift
12

Files

https://bmjopen.bmj.com/content/bmjopen/12/6/e055963.full.pdf https://europepmc.org/articles/PMC9234799?pdf=render

Datenquelle: Europe PubMed Central

Abstract
OBJECTIVES: To investigate German physicians' attitudes towards and experiences with voluntary disclosure of payments by pharmaceutical companies in a public database and their impact on future decisions for or against disclosure. DESIGN: A national cross-sectional survey conducted in 2018 among physicians who voluntarily disclosed at least one payment in the German transparency regulation. SETTING: Retrospective paper-pencil questionnaire about attitudes towards and experiences with voluntary payment disclosures in the first (2015) and second (2016) years of the German transparency regulation. PARTICIPANTS: German physicians who disclosed either in the first year only, the second year only, or in both years of the transparency regulation. PRIMARY OUTCOMES: (1) The probability to disclose in 2016, predicted by physicians' experience of reactions from others in 2015, descriptive norms and attitudes towards transparency; (2) Frequency and (3) Content of reactions from others in 2015 compared with 2016. RESULTS: Data of 234 respondents were analysed (n=42, 45 and 147 physicians who disclosed in 2015, 2016 or both years, respectively). The probability to disclose in 2016 was not predicted by perceived reactions, norms or attitudes towards transparency (p>0.01). Most participants reported not to have received any reactions by patients (190/234, 81%), colleagues (128/234, 55%) or the private environment (153/234, 65%). Neither frequency nor content of reactions differed between the first and second years (scale 1-5; frequency: Mdn2015,2016 = 1.33 vs 1.00, rb=-0.17, p>0.01; content: Mdn2015,2016 = 3.00 vs 3.00, rb=0.19, p>0.01). However, media reporting, fear of reputational damage and a feeling of being defamed were mentioned as reasons for non-disclosure. CONCLUSIONS: While confirmatory analyses did not provide significant results, descriptive analyses showed that participants who voluntarily disclose payments mainly do not experience any reactions towards their disclosures but report fears about losing their reputation due to disclosures.
Autoren
  • Marlene Stoll
  • Lara Hubenschmid
  • Cora Koch
  • Klaus Lieb
  • Boris Egloff
Autoren-URL
https://www.ncbi.nlm.nih.gov/pubmed/35750457
DOI
10.1136/bmjopen-2021-055963
eISSN
2044-6055
Externe Identifier
  • PubMed Central ID: PMC9234799
Ausgabe der Veröffentlichung
6
Zeitschrift
BMJ Open
Schlüsselwörter
  • health policy
  • medical ethics
  • protocols & guidelines
  • Attitude
  • Conflict of Interest
  • Cross-Sectional Studies
  • Disclosure
  • Drug Industry
  • Humans
  • Pharmaceutical Preparations
  • Physicians
  • Retrospective Studies
Sprache
eng
Country
England
Paginierung
e055963
PII
bmjopen-2021-055963
Datum der Veröffentlichung
2022
Status
Published online
Datum, an dem der Datensatz öffentlich gemacht wurde
2022
Titel
Physicians' attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey.
Sub types
  • Journal Article
  • Research Support, Non-U.S. Gov't
Ausgabe der Zeitschrift
12

Datenquelle: PubMed

Beziehungen:
Eigentum von

Werkzeuge